“Advanced Glycation End Products Inhibit Prohormone Processing: Implications for Diabetes and Obesity”

https://pubmed.ncbi.nlm.nih.gov/38112318

Advanced glycation end products (AGEs) can inhibit the processing of prohormones to active hormones, including proinsulin conversion to insulin, suggesting a novel pathomechanism for diabetes and obesity development.